Back to the Library
Three Jenner & Block practices – Content, Media & Entertainment (CME), Intellectual Property, and Restructuring and Bankruptcy – have been named Law360 Practice Groups of the Year for 2015. This marks the third consecutive year that the CME Practice has been so honored and the second consecutive year for the Restructuring and Bankruptcy Practice. This is the first year the IP practice has been honored.
In its profile of the CME Practice, Law360 notes “decisive” copyright victories that included successfully defending rapper Jay Z in two copyright suits. The article also notes the $50 million settlement on behalf of record labels Universal Music Group, Sony Music Entertainment and Warner Music Group against online music service Grooveshark. Practice Co-Chair Andrew H. Bart is quoted, attributing the team’s success to its deep bench strength that spans the breadth of the television, film and music industries. “We are thought partners with our clients who address their issues before, during and after lawsuits are brought. We really work as an integrated industry practice that tries to anticipate where the industry is going and work with our client to address challenges to their business model and risks going forward,” Mr. Bart tells Law360.
In its profile of the Intellectual Property Practice, Law360 says the firm’s roughly 70 IP lawyers around the United Statesbring “some serious IP firepower” to their clients’ cases. Successes from 2015 include representing Hospira Inc. in a major appeal over patents for a popular blood thinning drugto nabbing a copyright win for the estate of Elaine Steinbeck, along with ongoing representation of healthcare software company Epic Systems in the trade secrets arena. In the Hospira case, although a rehearing has been granted in the Federal Circuit, our client was able to launch a generic version of the drug in July. Bradford P. Lyerla, co-chair of the Patent Litigation and Counseling Practice, is quoted saying that the firm is becoming very involved with biosimilar patents; he predicts that there will be a “tidal wave” of biosimilar litigation in the coming years. “There are a number of biosimilar drugs being applied for – and will be applied for – in the coming year or two,” Mr. Lyerla tells Law360. “And there’s going to be lots and lots and lots of litigation. And this has become a really big part of our practice.”
In its profile of the Restructuring and Bankruptcy Practice, Law360 highlights last year’s winning argument for client Wellness International “in perhaps the most important bankruptcy case the US Supreme Court heard in 2015.” The article also notes the team’s continued efforts to guide Caesars Entertainment as its operating unit goes through Chapter11, as well as other matters. And it mentions the addition of Partner Richard Levin, now co-chair of the practice, who joined us last year. Practice Co-Chair Catherine L. Steege, who handled the oral argument in Wellness, is quoted saying, “We really have a fantastic group of people here. All of our partners have done a lot of very good things for their clients and that’s helped the group be where it is.”